Heart failure in women: An equal opportunity player in the expanding epidemic of heart failure

Gerin R. Stevens; Jill Kalman

doi:10.1007/s12170-008-0040-1

Heart failure in women: An equal opportunity player in the expanding epidemic of heart failure

Gerin R. Stevens, Jill Kalman

School of Medicine

Research output: Contribution to journal › Article

Abstract

Heart failure has been described as an epidemic with increasing incidence and prevalence with the aging of the general population. Sex plays an important role in heart failure management given that women with heart failure typically are older, have nonischemic etiologies more often, and have better ventricular function than men with heart failure. This translates into better outcomes for women regardless of the cause of heart failure. Important differences exist in disease in women and men admitted with heart failure, and diagnostic and treatment strategies significantly differ. Despite a National Institutes of Health mandate in 1993, women are still underrepresented in clinical trials, making it difficult to extrapolate treatment data in a meaningful way.

Original language	English (US)
Pages (from-to)	210-216
Number of pages	7
Journal	Current Cardiovascular Risk Reports
Volume	2
Issue number	3
DOIs	https://doi.org/10.1007/s12170-008-0040-1
State	Published - Dec 1 2008

Fingerprint

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Cite this

Stevens, G. R., & Kalman, J. (2008). Heart failure in women: An equal opportunity player in the expanding epidemic of heart failure. Current Cardiovascular Risk Reports, 2(3), 210-216. https://doi.org/10.1007/s12170-008-0040-1

@article{5c58ff573bc847d29f99e69bf24f1f63,

title = "Heart failure in women: An equal opportunity player in the expanding epidemic of heart failure",

abstract = "Heart failure has been described as an epidemic with increasing incidence and prevalence with the aging of the general population. Sex plays an important role in heart failure management given that women with heart failure typically are older, have nonischemic etiologies more often, and have better ventricular function than men with heart failure. This translates into better outcomes for women regardless of the cause of heart failure. Important differences exist in disease in women and men admitted with heart failure, and diagnostic and treatment strategies significantly differ. Despite a National Institutes of Health mandate in 1993, women are still underrepresented in clinical trials, making it difficult to extrapolate treatment data in a meaningful way.",

author = "Stevens, {Gerin R.} and Jill Kalman",

year = "2008",

month = dec

day = "1",

doi = "10.1007/s12170-008-0040-1",

language = "English (US)",

volume = "2",

pages = "210--216",

journal = "Current Cardiovascular Risk Reports",

issn = "1932-9520",

publisher = "Current Medicine Group",

number = "3",

}

TY - JOUR

T1 - Heart failure in women

T2 - An equal opportunity player in the expanding epidemic of heart failure

AU - Stevens, Gerin R.

AU - Kalman, Jill

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Heart failure has been described as an epidemic with increasing incidence and prevalence with the aging of the general population. Sex plays an important role in heart failure management given that women with heart failure typically are older, have nonischemic etiologies more often, and have better ventricular function than men with heart failure. This translates into better outcomes for women regardless of the cause of heart failure. Important differences exist in disease in women and men admitted with heart failure, and diagnostic and treatment strategies significantly differ. Despite a National Institutes of Health mandate in 1993, women are still underrepresented in clinical trials, making it difficult to extrapolate treatment data in a meaningful way.

AB - Heart failure has been described as an epidemic with increasing incidence and prevalence with the aging of the general population. Sex plays an important role in heart failure management given that women with heart failure typically are older, have nonischemic etiologies more often, and have better ventricular function than men with heart failure. This translates into better outcomes for women regardless of the cause of heart failure. Important differences exist in disease in women and men admitted with heart failure, and diagnostic and treatment strategies significantly differ. Despite a National Institutes of Health mandate in 1993, women are still underrepresented in clinical trials, making it difficult to extrapolate treatment data in a meaningful way.

UR - http://www.scopus.com/inward/record.url?scp=84873487784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873487784&partnerID=8YFLogxK

U2 - 10.1007/s12170-008-0040-1

DO - 10.1007/s12170-008-0040-1

M3 - Article

AN - SCOPUS:84873487784

VL - 2

SP - 210

EP - 216

JO - Current Cardiovascular Risk Reports

JF - Current Cardiovascular Risk Reports

SN - 1932-9520

IS - 3

ER -

Access to Document

10.1007/s12170-008-0040-1